dr. jahanzeb on overcoming her2 resistance in breast cancer
Published 8 years ago • 434 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
2:06
dr. jahanzeb on the aphinity and extenet trials in breast cancer
-
1:03
dr. jahanzeb on the future of adjuvant therapy in her2 breast cancer
-
1:53
dr. jahanzeb discusses advancements in adjuvant her2 breast cancer
-
1:13
dr. hamilton on overcoming resistance to her2-targeted therapy in breast cancer
-
1:02
dr. mohammad jahanzeb on neratinib and trastuzumab in her2-positive breast cancer
-
0:45
dr. davis on immunotherapy in her2-positive gastric/gej cancer
-
1:19
dr. jahanzeb on the benefit of pertuzumab plus trastuzumab in her2 breast cancer
-
2:09
adjuvant therapy data for her2-positive breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
6:01
treating low-risk her2-positive breast cancer
-
3:59
her2 mutations in breast cancer
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
2:51
breast cancer: extended adjuvant therapy and cost factors